Age-Related Macular Degeneration (AMD) - Usability Study
Launched by NOTAL VISION LTD. · Aug 20, 2009
Trial Information
Current as of June 04, 2025
Completed
Keywords
ClinConnect Summary
The AMD usability study is a prospective, longitudinal, multi-center, observational study of patients diagnosed with intermediate (dry) AMD who have been asked by their doctor to use the ForeseeHomeTM device to record the natural progression of their AMD, including conversion from the dry to wet stage.
Gender
ALL
Eligibility criteria
- • Inclusion criteria
- • Subjects diagnosed as intermediate AMD in at least one eye
- • Visual Acuity (VA) with habitual correction \<20/60 in the study eye
- • Qualified in the clinic to use the device
- • Ability to speak, read and understand instructions in English
- • Subjects with ability to comprehend and sign the informed consent/authorization
- • Exclusion criteria
- • Evidence of macular disease other than AMD or glaucoma in the study eye
- • Presence of any significant media opacity that precludes a clear view of the macular area as identified in the study eye by biomicroscopy
- • Any non-macular related ocular surgery performed within 3 months prior to study entry in the target eye
About Notal Vision Ltd.
Notal Vision Ltd. is an innovative medical technology company dedicated to advancing the field of ophthalmology through the development of cutting-edge diagnostic and monitoring solutions. With a focus on improving patient outcomes and enhancing the management of retinal diseases, Notal Vision leverages its expertise in artificial intelligence and data analytics to create tools that empower both healthcare providers and patients. The company is committed to rigorous clinical research and collaboration, ensuring that its products meet the highest standards of efficacy and safety while addressing the evolving needs of the ophthalmic community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Daniel Roth, MD
Principal Investigator
Vitreos retina center - NJ
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials